top of page

SAMHSA TO ISSUE INTERIM MEASURES IF BUPRENORPHINE RULE DELAYED

SAMHSA (2/10) -- HHS has says that if the SAMHSA is unable to complete rulemaking that allows providers in opioid treatment programs to continue to initiate buprenorphine following a telehealth visit before the May 11 end of the public health emergency, SAMHSA will enact interim measures to bridge any gap that may result after the PHE ends. Cont.

5 views0 comments

Recent Posts

See All

SAMHSA [18-July] | SAMHSA is marking the one year-anniversary since the 988 Suicide and Crisis Lifeline was launched. In honor of one-year in service, SAMHSA’s 988 Lifeline team has updated the 988 Pa

bottom of page